- Open Access
Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularisation, based on late gadolinium enhancement Cardiovascular Magnetic Resonance
Journal of Cardiovascular Magnetic Resonance volume 12, Article number: 56 (2010)
The new gold standard for myocardial viability assessment is late gadolinium enhancement-cardiovascular magnetic resonance (LGE-CMR); this technique has demonstrated that the transmural extent of scar predicts segmental functional recovery. We now asked how the number of viable and number of viable+normal, segments predicted recovery of global left ventricular (LV) function in patients undergoing CABG. Finally, we examined which segmental transmural threshold of scarring best predicted global LV recovery.
Methods and Results
Fifty patients with reduced LV ejection fraction (EF) referred for CABG were recruited, and 33 included in this analysis. Patients underwent CMR to assess LV function and viability pre-operatively at 6 days and 6 months. Mean LVEF 38% ± 11, which improved to 43% ± 12 after surgery. 21/33 patients improved EF by ≥3% (EF before 38% ± 13, after 47% ± 13), 12/33 did not (EF before 39% ± 6, after 37% ± 8). The only independent predictor for global functional recovery after revascularisation was the number of viable+normal segments: Based on a segmental transmural viability cutoff of <50%, ROC analysis demonstrated ≥10 viable+normal segments predicted ≥3% improvement in LVEF with a sensitivity of 95% and specificity of 75% (AUC = 0.9, p < 0.001). Transmural viability cutoffs of <25 and <75% and a cutoff of ≥4 viable segments were less useful predictors of global LV recovery.
Based on a 50% transmural viability cutoff, patients with ≥10 viable+normal segments improve global LV function post revascularisation, while patients with fewer such segments do not. LGE-CMR is a simple and powerful tool for identifying which patients with impaired LV function will benefit from CABG.
Research Ethics Committee Unique Identifier: NRES:05/Q1603/42. The study is listed on the Current Controlled Trials Registry: ISRCTN41388968.
In some patients with coronary artery disease and impaired left ventricular (LV) function, revascularisation by coronary artery bypass grafting (CABG) improves both symptoms and prognosis, while in the absence of significant viability, revascularisation offers little prognostic benefit. Several studies have directly linked post-surgical improvement in LV ejection fraction (EF) and symptoms to the presence of significant viable myocardium[3–6]. Viability testing is now an integral part of the assessment of patients with impaired LV function and coronary artery disease considered for revascularisation.
Over the last decade, LGE-CMR has emerged as a simple and highly reproducible tool for assessing both myocardial injury and viability. The seminal work by Kim et al. demonstrated that the transmural extent of myocardial injury predicted regional functional recovery on a segmental level. However, even more important than the issue of segmental recovery is the question of identifying which patients with poor LV function will show recovery of global LV function after revascularisation, and which will not. Studies using positron emission tomography (PET) and Dobutamine Stress Echo (DSE) have started to define the numbers of viable segments, based on a 16 segment model, associated with global functional recovery. Bax et al. demonstrated functional recovery in patients with 4 or more viable segments on DSE, with an approximate sensitivity of 84% and specificity of 81%. More recently Slart et al. showed that 3 or more viable segments defined by FDG uptake by PET, predicted global functional recovery with a sensitivity and specificity of 87% and 85%, respectively. However, unlike LGE-CMR, these methods cannot define the segmental transmural extent of scar. With LGE-CMR increasingly becoming the gold standard for viability imaging, it is important to understand how both the number of viable segments and the transmural extent of viability, assessed by LGE-CMR, predicts global recovery of LV function.
We have reported the results of a randomised trial comparing cardioplegic arrest CABG (ONSTOP) to a novel method for intra-operative myocardial protection (on-pump beating heart, ONBEAT) . This study used CMR to image patients with heart failure undergoing CABG before, at 6 days and at 6 months after surgery. Using data from this unique cohort, we asked two simple, practical questions: Based on a 16 segment AHA model (omitting the true apex), does the sum of viable segments or the sum of viable+normal segments provide the stronger cutoff criteria for global LV recovery? Secondly, what cutoff for segmental transmural extent of viability best predicts recovery?
The methods have been described in detail before. Patients with impaired LV function accepted for surgery were recruited if they consented and had no contra-indications to CMR or gadolinium contrast. Recruited patients included both elective admissions and patients with recent unstable coronary syndromes requiring inpatient revascularisation; patients with Class IVb angina were excluded. All elective patients were assessed with CMR within 4 weeks of their surgery, whilst all urgent in-hospital referrals for CABG underwent their pre-operative CMR assessment the evening before surgery. This study complies with the Declaration of Helsinki, a locally appointed ethics committee had approved the research protocol (NRES:05/Q1603/42), all patients gave written informed consent.
Treatment and Procedures
The aim of CABG was to obtain complete revascularisation, all territories were assumed to be revascularised, intra operative graft imaging was routinely undertaken.
All CMR examinations were performed using a 1.5 Tesla MR scanner (Sonata, Siemens Medical Solutions, Erlangen, Germany), using prospective gating. After piloting, steady-state free precession cine images (temporal resolution 24 - 45 ms; TE/TR 1.5/3.0 ms, flip angle 60o) were acquired. The short axis stack was acquired parallel to the AV groove in 1 cm increments (slice thickness 7 mm, inter-slice gap 3mm).
LGE-CMR was performed with a T1-weighted segmented inversion-recovery turbo fast low-angle shot (FLASH) sequence (echo time 4.8ms, voxel size 1.4 × 2.4 × 7 mm, flip angle 20°) following a 6 minute time delay after the administration of 0.1 mmol/kg contrast agent (Gadodiamide, Omniscan™, GE Healthcare). The inversion time was meticulously adjusted for optimal nulling of remote normal myocardium.
Post Processing Analysis
The methods for analysing and calculating LV volumes and LGE are standardised within our unit and, along with the reproducibility, have been published [11, 12]. Left ventricular volumetric analysis used the short axis ventricular stack and was analysed using Argus software (Version 2002B, Siemens Medical Solutions) by a single experienced observer (J.M.F) blinded to RWM and LGE findings. Manual tracing of endocardial borders in each successive slice position at the chosen end diastolic and end systolic phase was performed. The basal slice was selected if its circumference comprised at least 50% of myocardium. Papillary muscle was included in the LV mass and excluded from the LV volume. Visual assessment of regional wall motion score (RWMS) using Argus software (Version 2002B, Siemens Medical Solutions) was undertaken by two experienced observers working in consensus and blinded to the LGE findings. Segments were graded 1-normally contracting to 5-dyskinetic. Improvement in regional contraction was defined by an improvement of ≥1 functional grade (with the exception of improvement from grade 5 to grade 4).
Transmural extent of myocardial infarction was quantified by a computer assisted planimetry programme, MATLAB version 22.214.171.1247 (Natick USA) by a single experienced operator, with areas of myocardial infarction determined as areas with signal intensity >2 S.D above remote normal myocardium. Semi-quantitative approach with operator override was employed to categorize the transmural extent of hyperenhancement into subgroups: 0 = no LGE, 1 = 1-25% LGE, 2 = 26-50% LGE, 3 = 51-75% LGE and 4 > 75% LGE. Inter-observer variability for transmurality grading was checked for 15 patients by a second blinded observer, with a kappa = 0.872, indicating a good level of agreement. To calculate the mass of LGE, we assumed a specific gravity of 1.05 g/cm3.
Registration of segments
For visual assessment of transmural extent of scar and RWM, two models, based on either a 48 segment (6 slices × 8 segments) or the AHA 16 segment model (excluding segment 17 - apex) was used. The basal slice was defined as the first slice without LVOT in any phase of the cardiac cycle. Segment 1 was defined at the anterior insertion of the right ventricle into the inter-ventricular septum. Registration of segments for LGE-CMR and regional wall motion scores was undertaken in a paired manner by a single observer 6 months prior to visual analysis. For the 16 segment AHA model, the mid-ventricular slice was defined as 20 mm below the base, on condition that it contained papillary muscle but no trabeculation, similarly the apical slice was defined as 20 mm below the mid ventricular slice on condition that it contained trabeculation but no papillary muscle.
There was an excess in myocardial injury associated with the ONBEAT technique, therefore we excluded patients with evidence of new myocardial injury based on their early post operative scan or on the presence of significantly elevated troponin levels following surgery (in patients not able to complete imaging at 6 days). The main comparisons of the study are between patients with functional recovery and patients without improvement in LVEF.
Values were expressed as mean (SD) or median (inter-quartile range, 25% to 75%). The effect of revascularisation was compared using a paired t-test and dichotomous data was compared by the χ2 statistic or Fisher's exact test. Continuous variables that were not distributed normally were compared by the Mann-Whitney test.
To compare the transmural extent of scar and regional functional recovery, a logistic generalised estimating equation model accounting for non-independence of the data within each subject was used. To examine the impact of the number of non-viable segments on regional recovery in viable segments, a similar logistic generalised estimating equation model was used, adjusting for baseline LGE, surgical technique, ESVI and EF. For both analyses, both the independent (no adjustments made for within subject correlation of the data) and AR1 models (accounting for within subject correlation in the data) were examined with no effect on the results. The AR1 model is reported. A probability of p < 0.05 was considered statistically significant.
Due to the number of independent variables involved in determining late LV recovery, we adopted a model building strategy to assess the potential association between baseline variables and change in EF at 6 months. We first performed a simple regression analysis to examine any potential association between the baseline variables (i.e. age, sex, BMI, ONBEAT versus ONSTOP, number of grafts, total mass of LGE, % Left anterior descending artery (LAD) territory affected by >50% LGE, number of viable segments, number of viable+normal segments, time between surgery and CMR scan, pre-operative LVEF and ESVI) and late change in EF. Variables with p < 0.1 were then included in the multiple linear regression using an enter selection method to assess the best factors for predicting change in LV function.
Receiver Operating Characteristic (ROC) analysis was performed to determine the number of viable segments, and the number of viable+normal segments, that best predicts recovery of global function, where improvement is defined as ≥3% absolute change in LVEF.
Patients recruited and excluded from this study are presented in Figure 1. Data analysis is based on 33 patients. Mean pre-operative LVEF for patients was 38% ± 11, mean pre-operative regional wall motion score (RWMS) was 2.4 ± 0.7. Eight patients had recent evidence (< 28 days) of acute coronary syndrome. There was an excellent linear relationship between baseline EF and mean RWMS for each individual patient (r = 0.85, p < 0.0001).
All patients recruited had three vessel coronary artery disease or left main stem disease. The median number of grafts per patient was 4(3-4), all grafts were patent at the end of surgery. All patients were reviewed at 6 months, no patient had recurrent angina or an intervening hospital admission.
Prediction of regional segmental functional recovery
Prior to defining predictors of global recovery we wanted to ensure that the previously described relationship between transmural extent of viability and regional function recovery holds true for this cohort of patients with more severely impaired LV function. For this purpose it was necessary to use a 40 or 48 segment model similar to previous work[5, 14]. A total of 1408 segments were available for analysis, of which 957 segments were judged to be dysfunctional before revascularisation (68%). Furthermore, 718 segments had some degree of LGE (51%). In dysfunctional segments, there was progressive reduction in functional recovery with increasing extent of transmural infarction (p < 0.001) (Figure 2).
Overall, patients improved their LVEF from 38% ± 11 to 43% ± 12 (p < 0.001). Of dysfunctional segments affected by <50% LGE, 381/609 (63%) improved contraction by 6 months. Segments with <50%LGE were considered "viable" for this purpose. In patients, the number of viable and viable+normal (<50% scar) segments, not the mass of LGE, had linear relationships with the percentage of viable segments that demonstrated recovery of function (Figure 3i and ii). This association was maintained after adjusting for baseline ESVI, EF, surgical technique and the extent of LGE in these viable segments (p < 0.001).
Patient response to coronary artery bypass grafting
An improvement in EF of ≥3% was demonstrated in 21/33 patients (64%), and the characteristics of patients with and without significant improvement in LVEF are given in Table 1.
Prediction of global functional recovery based on the 16 segment AHA model
The relationship between the number of viable+normal segments (< 50% transmural scar) (Figure 4, panel i) and change in EF was linear. A lesser relationship was demonstrated when the number of viable segments was considered (Figure 4, panel ii). Using a multivariate model, only the sum of viable+normal segments (but not the number of viable segments) was shown to independently predict change in EF 6 months following revascularisation (Table 2 and Figure 4, panel i).
ROC analysis was used to best define a threshold for number of viable+normal segments and also the transmural extent of LGE within each segment that had the optimal sensitivity and specificity for predicting global functional recovery (Figure 5). For improvement in LVEF, 10 or more viable+normal segments (LGE <50%) demonstrated the optimal sensitivity of 95% and specificity of 75%. Furthermore, both the positive and negative predictive values were high (87% and 89% respectively) (AUC 0.90 p < 0.001, Figure 5). A transmural extent of LGE <50% was the best threshold to define segmental viability for the purpose of predicting global recovery, while other transmural cutoff thresholds were less powerful.
Patients with ≥10 viable+normal segments on LGE-CMR demonstrated both significant improvement in EF and reverse remodeling, whereas there was no evidence of a change in overall function or LV geometry at 6 months in patients with <10 viable+normal segments (Table 3).
The number of viable segments correlated very well with the mean change in regional wall motion score after CABG (Figure 6) but yielded a lower sensitivity and specificity for predicting global functional recovery. Four or more viable segments predicted ≥3% improvement in LVEF with a sensitivity of 76%, specificity of 42% (AUC 0.722, p = 0.04), clearly inferior to the number of viable+normal segments.
Finally, in line with convention we also examined a 5% threshold for improvement in LVEF, where 10 or more viable+normal segments had a sensitivity of 93%, specificity 49%, positive predictive value 56%, negative predictive value 90% and AUC 0.75, p = 0.02. Six patients who were defined at the 3% level for improvement in LVEF did not meet criteria for improvement at the 5% level. In these intermediate patients, ΔEF was +4 ± 0.6%, ΔEDVI -16 ± 15 ml.m-2, ΔESVI -13 ± 10 ml.m-2.
The most important findings of this single centre study are: Using a 16 segment model and a definition of segmental viability equaling <50% of transmural extent, the number of viable+normal segments demonstrated a linear relationship with improvement in ejection fraction and was able to predict patients with an overall improvement in EF of ≥3% at 6 months with high sensitivity and specificity. Significant recovery of global function and positive remodeling was present in patients with at least 10 viable+normal segments, but not in those with less than 10 viable+normal segments. These findings are of direct clinical relevance for clinicians making decisions about revascularisation in patients with impaired LV function in everyday practice.
Prediction of regional functional recovery
The study by Kim et al. was first to demonstrate a progressive loss of functional recovery with increasing transmural extent of LGE. Furthermore, they demonstrated that although 79% of segments without evidence of scar had improved contractility at 3 months, still a significant proportion had not. Similar work in patients with normal pre-operative EF imaged at 6 months found a slightly higher rate of functional recovery in segments without pre-existing LGE (82%). We similarly expected that imaging later and excluding patients with procedure related injury, would again optimize the proportion of viable segments with functional recovery after CABG. However, only 73% of unscarred segments in our cohort recovered. Our group differed from both that described by Kim et al. and Selvanayagam et al. in that our mean LVEF was lower (38 vs. 43 or 61%), and with a greater proportion of both dysfunctional and scarred segments. With a higher prevalence of scar, our finding that the number of scarred segments affected recovery of viable segments, may explain our lower rates of regional functional recovery.
Prediction of global functional recovery
We found that the number of viable+normal segments demonstrated a linear relationship with functional recovery and was the only independent predictor of the change in LVEF at 6 months, while the number of viable segments was not. Furthermore, other baseline variables such as mass of LGE did not demonstrate association with overall functional recovery. However, recruited patients included those with evidence of recent acute coronary syndrome, and myocardial infarction defined by CMR undergoes some degree of remodeling and contraction with age. Given the varying age of the myocardial scar in our patients, the lack of association is unsurprising.
Rizello et al.  using DSE, and Kim et al.  using LGE, first showed a linear relationship between the number of viable segments and the change in EF after revascularisation, although their analysis was not based on a 16 segment model, did not examine whether there is a cut off for the number of segments that predicted improvement of global function and did not include assessment of the sum of viable+normal segments. However, patients with documented viability often fail to recover global function subsequent to revascularisation. Studies investigating the diagnostic performance of viability assessment by different imaging modalities have shown that they are generally sensitive (81-93%) but less specific (58-80%). The lower specificity may be because of incorrect labeling of non viable segments (false positive), or for other reasons not relating to the imaging modality, including procedural injury (such patients were excluded in our study to eliminate this effect) , incomplete revascularisation, LV remodeling, and tethering by adjacent scarred segments.
The impact of LV remodeling on outcome after surgical revascularisation was first described by Yamaguchi et al. They identified that significant pre-operative LV dilation (ESVI >100ml.m-2) was associated with a poor post-operative outcome, although no measure of viability was made in this study. Further to this, Bax et al. suggested that in patients with substantial viability (≥25% LV), sub groups with extensive pre-operative remodeling (ESV ≥140 ml) do not show substantial improvement in LVEF following CABG. In a cohort comparable to the latter study, we found no relationship between pre-operative ESVI and change in either global or regional function after revascularisation. However, our numbers are relatively small and it is conceivable that in a larger study ESVI may emerge as a secondary determinant of change in LVEF.
Finally, our finding that the number of viable+normal segments was related to recovery in other viable segments supports the notion that tethering by scar tissue may prevent regional and global recovery.
Analysis based on number of viable segments vs. number of viable+normal segments
Previous studies have based prediction of global recovery on the number of viable segments (defined as segments that are dysfunctional but viable, with the ability to recover after revascularisation)[3, 9], but our study introduces the concept that the sum of viable+normal segments may be a better predictor. To illustrate this, let us consider two hypothetical patients. Patient A has 4 viable, 7 non-viable and 3 normal segments, while patient B has 4 viable, 0 non-viable and 10 normal segments. The number of viable segments is the same (4) for both patients, but the sum of viable+normal segments is 7 vs. 14. Intuitively, prognosis of these patients will be different post CABG. Thus, in our cohort, we analysed the predictive power of both the number of viable segments and the sum of viable+normal segments. This point is best exemplified in the current work in patients with mild LV dysfunction, few dysfunctional segments but in whom there was still a measurable improvement in LVEF at 6 months (Large circles: Figure 5, panels i and ii). Similar work from our group in patients with normal LV function showed similar improvement despite only 20% of analyzed segments being dysfunctional prior to surgery; with LVEF improving from 61% ± 11 to 67% ± 10 at 6 months. We hypothesize that visual assessment misses subtle LV systolic dysfunction, but the improvement is still detected by highly reproducible means such as volume assessment by CMR.
When examining change in regional wall motion scores, the number of viable (but not including normal) segments showed the better association. The latter is likely because analysis of change in regional wall motion score effectively excludes segments with normal baseline function, correlating only improved dysfunctional segments with the number of viable segments, hence the better association.
To include only viable segments in a reporting algorithm for overall functional improvement presumes that segments with normal baseline function sustain no further improvement after revascularisation and make no contribution to an increase in EF. Our data suggest that analysis should incorporate the sum of viable+normal, i.e. all segments able to contribute to the end-point.
Finally, although convention defined a threshold of 5% for clinically significant improvement in LVEF, this is not founded on prognostic data but more what was felt to be clinically relevant, which in the main part is determined by the reproducibility of transthoracic echo and LV angiography. CMR is able to detect a 3% change in LVEF with certainty. In the current study, we found that using a 5% threshold for improvement in LVEF missed several patients with significant (>10%) reduction in overall LV cavity size. Neither the 3% nor the 5% threshold has been shown to be of prognostic importance. Furthermore, Senior et al.  determined that an improvement in LV geometry, not 5% improvement in LVEF, was associated with improved outcome after CABG, and they conclude that any degree of LV remodeling is likely to be associated with a survival benefit. Any reproducibly detectable improvement in function after CABG is likely to be relevant to patients.
The major limitation of this study is the small sample size, and these findings, although interesting, should be considered preliminary. Follow up angiography was not undertaken as part of this study, and long-term graft patency cannot be excluded as a confounding factor. By chance, patients with significant improvement in LVEF had a statistically greater duration between surgery and the 3rd CMR scan. However, in practice, the difference was small and is unlikely to be of any clinical or biological relevance. Previous studies have used an arbitrary threshold of 5%, we however chose a threshold for functional recovery based upon the reproducibility of the technique. However, neither the 3% nor the 5% improvement in ejection fraction have been shown to translate to an improved outcome after surgery.
Our study suggests that the presence of 10 or more viable plus normal segments, based upon the AHA 16 segment format and defined as <50% transmural scar, predicts significant long term recovery of global LV function in patients with impaired EF undergoing CABG. This finding is important, and may provide a simple approach to identify those patients who derive functional and prognostic benefit from CABG.
Coronary Artery Bypass Grafting
Cardiovascular Magnetic Resonance Imaging
Dobutamine Stress Echocardiography
End systolic volume index
Late Gadolinium Enhancement
Positron Emission Tomography
Receiver Operating Curves
Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, Levine F, Schloss M: Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983, 68: 785-795.
Allman KC, Shaw LJ, Hachamovitch R, Udelson JE: Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002, 39: 1151-1158. 10.1016/S0735-1097(02)01726-6.
Bax JJ, Poldermans D, Elhendy A, Cornel JH, Boersma E, Rambaldi R, Roelandt JR, Fioretti PM: Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol. 1999, 34: 163-169. 10.1016/S0735-1097(99)00157-6.
Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW: Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 1993, 87: 1630-1641.
Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000, 343: 1445-1453. 10.1056/NEJM200011163432003.
Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME, Maddahi J: Quantitative Relation Between Myocardial Viability and Improvement in Heart Failure Symptoms After Revascularization in Patients With Ischemic Cardiomyopathy. Circulation. 1995, 92: 3436-3444.
Hendel RC, Patel MR, Kramer CM, Poon M, Hendel RC, Carr JC, Gerstad NA, Gillam LD, Hodgson JM, Kim RJ, et al: ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 Appropriateness Criteria for Cardiac Computed Tomography and Cardiac Magnetic Resonance Imaging: A Report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. Journal of the American College of Cardiology. 2006, 48: 1475-1497. 10.1016/j.jacc.2006.07.003.
Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM: Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol. 1997, 30: 1451-1460. 10.1016/S0735-1097(97)00352-5.
Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RA, de Boer J, Jager PL: Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET. J Nucl Cardiol. 2006, 13: 210-219.
Pegg TJ, Selvanayagam JB, Francis JM, Karamitsos TD, Maunsell Z, Yu LM, Neubauer S, Taggart DP: A randomized trial of on-pump beating heart and conventional cardioplegic arrest in coronary artery bypass surgery patients with impaired left ventricular function using cardiac magnetic resonance imaging and biochemical markers. Circulation. 2008, 118: 2130-2138. 10.1161/CIRCULATIONAHA.108.785105.
Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S: Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson. 2005, 7: 775-782. 10.1080/10976640500295516.
Porto I, Selvanayagam JB, Van Gaal WJ, Prati F, Cheng A, Channon K, Neubauer S, Banning AP: Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation. 2006, 114: 662-669. 10.1161/CIRCULATIONAHA.105.593210.
Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ: Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002, 90: 29-34. 10.1016/S0002-9149(02)02381-0.
Selvanayagam JB, Kardos A, Francis JM, Wiesmann F, Petersen SE, Taggart DP, Neubauer S: Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation. 2004, 110: 1535-1541. 10.1161/01.CIR.0000142045.22628.74.
Rizzello V, Poldermans D, Boersma E, Biagini E, Schinkel AF, Krenning B, Elhendy A, Vourvouri EC, Sozzi FB, Maat A, et al: Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy: role of myocardial viability. Circulation. 2004, 110: 2383-2388. 10.1161/01.CIR.0000145115.29952.14.
Schinkel AFL, Poldermans D, Elhendy A, Bax JJ: Assessment of Myocardial Viability in Patients with Heart Failure. J Nucl Med. 2007, 48: 1135-1146. 10.2967/jnumed.106.038851.
Bax JJ, Schinkel AF, Boersma E, Elhendy A, Rizzello V, Maat A, Roelandt JR, van der Wall EE, Poldermans D: Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation. 2004, 110: II18-22.
Beller GA: Comparison of 201Tl scintigraphy and low-dose dobutamine echocardiography for the noninvasive assessment of myocardial viability. Circulation. 1996, 94: 2681-2684.
Yamaguchi A, Ino T, Adachi H, Murata S, Kamio H, Okada M, Tsuboi J: Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann Thorac Surg. 1998, 65: 434-438. 10.1016/S0003-4975(97)01155-7.
Senior R, Lahiri A, Kaul S: Effect of revascularization on left ventricular remodeling in patients with heart failure from severe chronic ischemic left ventricular dysfunction. Am J Cardiol. 2001, 88: 624-629. 10.1016/S0002-9149(01)01803-3.
Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E, van Lingen A, Fioretti PM, Visser CA: Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation. 2001, 104: I314-318. 10.1161/hc37t1.094853.
This research was supported by a project grant from the British Heart Foundation (PG7 035). Additional support was also received from the Oxfordshire Health Services Research Committee (OHSRC grant G) and the Oxford NIHR Biomedical Research Centre.
The authors declare that they have no competing interests.
TJP carried out recruitment, analysis and drafted the manuscript. JBS assisted with the study design and was general supervisor to TJP. JJ performed data analysis. JMF acquired CMR images and performed analysis. TDK acquired CMR images and performed analysis. EDA performed data analysis. KLS performed the statistical analysis. DPT was principle investigator on the study and was general supervisor to TJP. SN was general supervisor for this work and interpreted the study findings. All authors have read and approved the contents of this manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Pegg, T.J., Selvanayagam, J.B., Jennifer, J. et al. Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularisation, based on late gadolinium enhancement Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson 12, 56 (2010). https://doi.org/10.1186/1532-429X-12-56
- Coronary Artery Bypass Grafting
- Functional Recovery
- Left Ventricular Function
- Global Left Ventricular
- Normal Segment